DocDollars

Sk Life Science, Inc.

NJ · United States · Reporting entity ID 100000726811

Total reported 2019–2025
$35.1M
#213 of 2,960 reporting companies — 0% of all reported industry payments
$15.5M in general payments across 114,105 records, plus $19.6M in research funding across 3,068 records.

How it breaks down

General payments $15,527,898
Research funding $19,567,148

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Sk Life Science, Inc. reported $35.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #213 of 2,960 reporting companies. 56% of that was research funding and 44% general payments such as consulting, speaking, food and travel. 114,105 general payment records and 3,068 research records were filed.

Common questions about Sk Life Science, Inc.

How much has Sk Life Science, Inc. paid US doctors?

Sk Life Science, Inc. reported $35,095,047 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $15,527,898 in general payments, $19,567,148 in research funding.

How does Sk Life Science, Inc. rank among drug and device companies?

It ranks #213 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Sk Life Science, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.